Polyinosinic-polycytidylic acid sodium

Modify Date: 2024-01-03 20:22:08

Polyinosinic-polycytidylic acid sodium Structure
Polyinosinic-polycytidylic acid sodium structure
Common Name Polyinosinic-polycytidylic acid sodium
CAS Number 42424-50-0 Molecular Weight 694.4
Density N/A Boiling Point N/A
Molecular Formula C19H27N7NaO16P2 Melting Point N/A
MSDS USA Flash Point N/A

 Use of Polyinosinic-polycytidylic acid sodium


Polyinosinic-polycytidylic acid sodium (Poly(I:C) sodium) is a synthetic analog of double-stranded RNA and an agonist of toll-like receptor 3 (TLR3) and retinoic acid inducible gene I (RIG-I)-like receptors (RIG-I and MDA5). Polyinosinic-polycytidylic acid sodium can be used as a vaccine adjuvant to enhance innate and adaptive immune responses, and to alter the tumor microenvironment. Polyinosinic-polycytidylic acid sodium can directly trigger cancer cells to undergo apoptosis[1][2].

 Names

Name polyinosinic-polycytidylic acid sodium salt
Synonym More Synonyms

 Polyinosinic-polycytidylic acid sodium Biological Activity

Description Polyinosinic-polycytidylic acid sodium (Poly(I:C) sodium) is a synthetic analog of double-stranded RNA and an agonist of toll-like receptor 3 (TLR3) and retinoic acid inducible gene I (RIG-I)-like receptors (RIG-I and MDA5). Polyinosinic-polycytidylic acid sodium can be used as a vaccine adjuvant to enhance innate and adaptive immune responses, and to alter the tumor microenvironment. Polyinosinic-polycytidylic acid sodium can directly trigger cancer cells to undergo apoptosis[1][2].
Related Catalog
Target

TLR3[2], RIG-I[2], MDA5[2], apoptosis[2]

In Vitro Polyinosinic-polycytidylic acid (20 ng/mL; 24 hours; WM793, WM278, WM239A, WM9 and 1205Lu cells) treatment strongly reduces viability from 100% in controls to 20%–50% within 24 hours[1]. Polyinosinic-polycytidylic acid (200 ng/mL; 24 hours; 1205Lu cells) treatment induces apoptosis in 1205Lu cells[1]. Polyinosinic-polycytidylic acid (3 ng/mL; 24 hours; 1205Lu cells) treatment induces IFN-β expression in melanoma cells. Silencing of RIG-I and MDA-5 confirmed that induction of IFN-β by Polyinosinic-polycytidylic acid required RIG-I and MDA-5, respectively, and that required IPS-1[1]. Polyinosinic-polycytidylic acid (5 ng/mL; 24 hours; 1205Lu cells) treatment reveals active subunits of caspase-9 and caspase-8 in melanoma cells[1]. Cell Viability Assay[1] Cell Line: WM793, WM278, WM239A, WM9 and 1205Lu cells Concentration: 20 ng/mL Incubation Time: 24 hours Result: Strongly reduced viability from 100% in controls to 20%–50% within 24 hours. Apoptosis Analysis[1] Cell Line: 1205Lu cells Concentration: 200 ng/mL Incubation Time: 24 hours Result: Induced apoptosis in 1205Lu cells. RT-PCR[1] Cell Line: 1205Lu cells Concentration: 3 ng/mL Incubation Time: 24 hours Result: Induced IFN-β expression in melanoma cells. Western Blot Analysis[1] Cell Line: 1205Lu cells Concentration: 5 ng/mL Incubation Time: 24 hours Result: Revealed active subunits of caspase-9 and caspase-8 in melanoma cells.
In Vivo Polyinosinic-polycytidylic acid treatment inhibits tumor growth in NOD/SCID immunodeficient mice injected with 1205Lu cells. The level of human DNA is 50% lower in mice treated with Polyinosinic-polycytidylic acid[1].
References

[1]. Besch R, et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest. 2009 Aug;119(8):2399-411.

[2]. Cheng YS, et al. Anticancer function of polyinosinic-polycytidylic acid. Cancer Biol Ther. 2010 Dec 15;10(12):1219-23.

 Chemical & Physical Properties

Molecular Formula C19H27N7NaO16P2
Molecular Weight 694.4
Storage condition −20°C
Water Solubility H2O: soluble10mg/mL

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes Xi
Safety Phrases 22-24/25
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS TR0175000

 Articles21

More Articles
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.

Oncotarget 6 , 37678-94, (2015)

Ewing sarcoma is an aggressive tumor of bone and soft tissue affecting predominantly children and young adults. Tumor-specific chromosomal translocations create EWS-FLI1 and similar aberrant ETS fusio...

WFDC1 is a key modulator of inflammatory and wound repair responses.

Am. J. Pathol. 184(11) , 2951-64, (2014)

WFDC1/ps20 is a whey acidic protein four-disulfide core member that exhibits diverse growth and immune-associated functions in vitro. In vivo functions are unknown, although WFDC1 is lower in reactive...

The broad pattern recognition spectrum of the Toll-like receptor in mollusk Zhikong scallop Chlamys farreri.

Dev. Comp. Immunol. 52 , 192-201, (2015)

Toll-like receptors (TLRs) are among the most studied pattern recognition receptors (PRRs) playing essential roles in innate immune defenses. In the present study, the basic features of CfTLR in mollu...

 Synonyms

MFCD00131984
Top Suppliers:I want be here





Get all suppliers and price by the below link:

Polyinosinic-polycytidylic acid sodium suppliers

Polyinosinic-polycytidylic acid sodium price